LadRx Corp
LADXDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000799698
LadRx Corp was delisted in 2025; its insiders filed their last Form 4 on Jan 29, 2024; no institution reported holding it in 13F filings for Q3 2025; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in LadRx Corp as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- 0 vs. Q2 2021
- Shares held
- 45.1K
- +11.6K (+34.6%) vs. Q2 2021
- Total value
- $27.0K
- −$6.00K (−18.2%) vs. Q2 2021
- New holders
- 1
- 0 more added
- Sold out
- 1
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LADX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $1 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $2 |
| Q3 2024 | 1 | $2 |
| Q2 2024 | 1 | $3 |
| Q1 2024 | 1 | $2 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $115 |
| Q3 2022 | 1 | $1.00K |
| Q2 2022 | 2 | $2.00K |
| Q1 2022 | 3 | $20.0K |
| Q4 2021 | 2 | $23.0K |
| Q3 2021 | 2 | $27.0K |
| Q2 2021 | 2 | $33.0K |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding LadRx Corp; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beck Mack & Oliver LLC | 33,500 | $20.0K | 0.00% | 00.0% | Unchanged |
| Colonial Trust Advisors | 11,584 | $7.00K | 0.00% | +11,584 | New |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |